Company intelligence / Profile preview
Sanyou Biopharmaceuticals
- Ownership
- Private
- Employees
- ~350
- Development stage
- Preclinical
Overview
Sanyou has a broad preclinical pipeline with multiple bispecific and monoclonal antibodies in discovery or preclinical stages targeting infectious diseases like COVID‑19 and monkeypox as well as oncology and autoimmune indications. The company’s platforms have enabled rapid response to public health crises; at least nine collaborative projects have obtained IND approval. Its technologies are widely used by global partners for both research-use-only reagents and therapeutic development.
- Therapeutic areas
- OncologyMetabolic DisordersImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodyBispecific antibodyAntibody-drug conjugateRecombinant proteinNanobody therapy
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Sanyou Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanyou Biopharmaceuticals.